| Drug Name |
Pindolol |
| Drug ID |
BADD_D01776 |
| Description |
Pindolol is a first generation non-selective beta blocker used in the treatment of hypertension.[L32353] Early research into the use of pindolol found it had chronotropic effects, and so further investigation focused on the treatment of arrhythmia.[A231059] Research into pindolol's use in the treatment of hypertension began in the early 1970s.[A231064]
Pindolol was granted FDA approval on 3 September 1982.[L32348] |
| Indications and Usage |
Pindolol is indicated in the management of hypertension.[L32353] In Canada, it is also indicated in the prophylaxis of angina.[L32388] |
| Marketing Status |
approved; investigational |
| ATC Code |
C07AA03 |
| DrugBank ID |
DB00960
|
| KEGG ID |
D00513
|
| MeSH ID |
D010869
|
| PubChem ID |
4828
|
| TTD Drug ID |
D0F2PO
|
| NDC Product Code |
72789-099; 72789-294; 49169-0006; 29033-028; 57664-655; 72789-293; 0378-0127; 76385-132; 62559-560; 70710-1063; 64330-109; 70771-1134; 70771-1135; 76385-131; 57664-656; 62559-561; 0378-0052; 72789-100; 29033-029; 70710-1064; 10135-743; 10135-744 |
| UNII |
BJ4HF6IU1D
|
| Synonyms |
Pindolol | Prindolol | Visken | LB-46 | LB 46 | LB46 |
